Chaffetz Vows Subpoena if Mylan Foot-Dragging Continues

By Sam | February 7, 2017

The House Oversight Committee threatened to subpoena Mylan for full documents related to price increases for its EpiPen.
Source: Drug Industry Daily

Posted in Drug Industry Daily